Quantum-Si incorporated
NASDAQ:QSIBiotechnology
+$0.05 today
- Market cap
- $213.79M
- Beta
- 3.17
- P/E (TTM)
- -2.1
- EPS (TTM)
- -$0.48
Volume 10.47M
Average 5.64M
QSI Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Quantum-Si incorporatedNASDAQ: QSI
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income growth accelerates
Q1 FY2026 net income of $21.67M (cash outflow) rose 12.9% year over year, ahead of the +3.1% change in trailing-twelve-month net income. Sequentially, it rose 23.1% from the prior quarter. Over 3 fiscal years it compounded at -8.5% a year.
Context
- Net income amounted to 4160.1% of revenue in FY2025, up 857.0 pp from a year earlier.
- Net income grew in size in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 2 analysts of -$88.9M (-12.3%) for the fiscal year ending Dec 2026, a slowdown from the +0.3% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$21.67M+23.1% QoQ
- Last fiscal yearDec 2025
- -$101.34M+0.3% YoY
- LTMMar 2026
- -$103.82M+3.1% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +12.9% | -13.9% | -26.9 pp |
| 1 year | +0.3% | -12.3% | -12.6 pp |
| 3-year CAGR | -8.5% | -19.4% | -10.9 pp |
| 5-year CAGR | -27.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- (101.34M) USD
- Year-over-year change
- -0.3%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (101.34M) | -0.3% |
| FY2024 | 2024-12-31 | (101.01M) | -5.3% |
| FY2023 | 2023-12-31 | (95.96M) | +27.5% |
| FY2022 | 2022-12-31 | (132.44M) | -39.4% |
| FY2021 | 2021-12-31 | (94.99M) | — |
Net Income vs competitors
How QSI compares with its peers on the latest reported figures
- QSI's LTM Mar 2026 net income of $103.82M is the 9th largest of the 11 companies compared; the peer median is $152.23M.
- Its year-over-year change of +3.1% is the 7th highest of 10, against a peer median of +18.7%.
- Net income amounts to 5605.9% of revenue for QSI, versus a peer median of 312.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $288.97M | +21.3% | +24.5% | 312.1% | |
| LTM Mar 2026 | $209.38M | -18.9% | +0.2% | — | |
| LTM Mar 2026 | $196.48M | +17.4% | +13.3% | — | |
| LTM Mar 2026 | $191.78M | +37.3% | +26.6% | — | |
| LTM Mar 2026 | $167.47M | +47.3% | +15.1% | — | |
| LTM Mar 2026 | $136.99M | -8.6% | -3.2% | 173.0% | |
ENGNenGene Holdings Inc. | LTM Apr 2026 | $126.85M | +58.8% | +68.6% | — |
| LTM Mar 2026 | $112.39M | +18.7% | +21.8% | — | |
| LTM Mar 2026 | $103.82M | +3.1% | -8.5% | 5605.9% | |
| LTM Mar 2026 | $91.08M | +0.9% | +1.3% | 253002.8% | |
LBRXLB Pharmaceuticals Inc Common Stock | LTM Mar 2026 | $39.17M | — | +20.7% | — |
| Peer median (excluding QSI) | $152.23M | +18.7% | +17.9% | 312.1% | |
Competitors are the stored peer set for QSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (94.99M) | (132.44M) | (95.96M) | (101.01M) | (101.34M) |
| Depreciation & Amortization | 1.04M | 2.58M | 4.16M | 4.6M | 4.45M |
| Deferred Income Tax | 714K | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 24.92M | 11.21M | 8.52M | 8.89M | 10.77M |
| Change in Working Capital | 1.47M | 3.05M | (3.2M) | 4.64M | (4.58M) |
| Accounts Receivables | 0 | 0 | (368K) | (1.09M) | 626K |
| Inventory | 0 | 0 | 286K | 4.34M | (2.01M) |
| Accounts Payables | 709K | 721K | (1.22M) | 390K | (338K) |
| Other Working Capital | 758K | 2.33M | (1.89M) | 1M | (2.86M) |
| Other Non-Cash Items | 36K | 25.04M | (7.55M) | (4.92M) | (4.03M) |
| Operating Cash Flow | (66.81M) | (90.56M) | (94.04M) | (87.8M) | (94.72M) |
| Capital Expenditures | (5.76M) | (10.74M) | (5.27M) | (4.58M) | (2.52M) |
| Acquisitions (Net) | (4.63M) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (440.54M) | (834K) | (123.81M) | (369.43M) | (404.58M) |
| Sales of Investments | 445.17M | 148.76M | 272.51M | 341.4M | 378.78M |
| Other Investing Activities | (445.17M) | 0 | (763K) | (59K) | 0 |
| Investing Cash Flow | (450.94M) | 137.19M | 143.43M | (32.68M) | (28.32M) |
| Debt Repayment | (1.78M) | 0 | 0 | 0 | 0 |
| Common Stock Issued | 512.79M | 2.76M | 0 | 34.79M | 95.42M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 5.61M | (848K) | 149K | 1.09M | 1K |
| Financing Cash Flow | 516.63M | 1.91M | 149K | 35.88M | 95.42M |
| Effect of Forex Changes | 0 | 0 | 0 | (25K) | 12K |
| Net Change in Cash | (1.13M) | 48.53M | 49.54M | (84.62M) | (27.6M) |
| Free Cash Flow | (72.58M) | (101.3M) | (99.31M) | (92.38M) | (97.23M) |
Quantum-Si incorporated
NASDAQ:QSI
Intrinsic Alpha fair value
Locked
Current Price
$1.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.